0,847  0,004  Eye irritation, high
0,844  0,004  GST A substrate
0,811  0,004  Cardiovascular analeptic
0,785  0,004  Skin irritative effect
0,796  0,016  Antiinflammatory
0,746  0,005  Lipoprotein disorders treatment
0,725  0,001  Alcohol dehydrogenase substrate
0,684  0,009  Aldehyde oxidase inhibitor
0,641  0,003  Acaricide
0,641  0,005  Hypolipemic
0,647  0,013  Cholesterol antagonist
0,648  0,018  TNF expression inhibitor
0,642  0,021  Cyclophilin D inhibitor
0,642  0,021  Antidiabetic
0,624  0,004  Alpha-N-acetylglucosaminidase inhibitor
0,619  0,005  FMO1 substrate
0,643  0,031  Caspase 9 stimulant
0,621  0,012  Atherosclerosis treatment
0,613  0,006  Platelet antagonist
0,598  0,003  Vanilloid agonist
0,591  0,003  Alcohol oxidase inhibitor
0,588  0,007  Antiglaucomic
0,593  0,012  Antipruritic, allergic
0,593  0,015  Antiallergic
0,582  0,011  Antipsoriatic
0,594  0,029  CYP3A4 substrate
0,580  0,018  Antihypercholesterolemic
0,571  0,015  CTGF expression inhibitor
0,565  0,015  Immunomodulator
0,559  0,020  Carcinogenic
0,545  0,008  Antihypertriglyceridemic
0,557  0,026  Embryotoxic
0,547  0,020  5 Hydroxytryptamine release stimulant
0,531  0,007  UGT2B4 substrate
0,539  0,017  GABA C receptor rho-3 antagonist
0,544  0,023  Antithrombotic
0,532  0,016  NOS3 expression inhibitor
0,550  0,036  Antineoplastic (solid tumors)
0,542  0,028  Teratogen
0,567  0,056  Apoptosis agonist
0,527  0,017  UGT1A9 substrate
0,512  0,004  GST P1-1 substrate
0,519  0,015  Antidiabetic (type 2)
0,514  0,010  Antidiabetic symptomatic
0,515  0,028  5 Hydroxytryptamine release inhibitor
0,505  0,021  Hepatic disorders treatment
0,502  0,032  Immunosuppressant
0,490  0,021  Mutagenic
0,478  0,011  Interleukin 2 agonist
0,472  0,006  Platelet adhesion inhibitor
0,469  0,008  Diabetic retinopathy treatment
0,485  0,024  Sensitization
0,489  0,029  CYP2C19 substrate
0,459  0,004  Neurotrophic factor
0,468  0,014  UDP-glucuronosyltransferase substrate
0,466  0,014  Vascular (periferal) disease treatment
0,473  0,023  Antioxidant
0,474  0,025  Analeptic
0,453  0,009  Abortion inducer
0,447  0,004  Succinate dehydrogenase inhibitor
0,448  0,005  Antipruritic, non-allergic
0,462  0,022  Antineoplastic (multiple myeloma)
0,452  0,014  Peroxidase inhibitor
0,445  0,007  GST M1-1 substrate
0,469  0,031  Ulceration
0,470  0,033  Bone diseases treatment
0,467  0,033  Respiratory analeptic
0,447  0,016  Radiosensitizer
0,467  0,036  Vasodilator, peripheral
0,441  0,013  Antimutagenic
0,447  0,020  Nitric oxide antagonist
0,466  0,043  CYP2C9 substrate
0,432  0,010  Antiseptic
0,432  0,010  Antiparkinsonian, rigidity relieving
0,447  0,028  Apoptosis antagonist
0,439  0,020  Superoxide dismutase inhibitor
0,435  0,017  Antihypoxic
0,438  0,020  Antiparasitic
0,460  0,045  Histamine release inhibitor
0,445  0,031  Caspase 3 stimulant
0,422  0,009  UGT2B7 substrate
0,431  0,020  UGT1A6 substrate
0,432  0,023  Hypoglycemic
0,417  0,010  Genotoxic
0,448  0,044  Toll-Like receptor agonist
0,411  0,009  Lipid peroxidase inhibitor
0,407  0,007  Tyrosine 3 hydroxylase inhibitor
0,417  0,019  Antineoplastic (endocrine cancer)
0,412  0,014  UGT1A4 substrate
0,429  0,033  Cardioprotectant
0,408  0,016  FMO3 substrate
0,428  0,042  Immunostimulant
0,406  0,021  Angiogenesis stimulant
0,432  0,047  CYP2C19 inhibitor
0,402  0,018  Interleukin agonist
0,400  0,019  Platelet aggregation inhibitor
0,402  0,023  Vasodilator
0,384  0,006  Aldehyde dehydrogenase inhibitor
0,397  0,020  Antiulcerative
0,397  0,022  DNA synthesis inhibitor
0,383  0,009  Protein kinase stimulant
0,379  0,005  GABA C receptor agonist
0,378  0,005  Carcinogenic, group 1
0,410  0,038  CYP1A2 substrate
0,388  0,018  Anesthetic general
0,426  0,058  Transcription factor NF kappa B inhibitor
0,415  0,054  Toll-Like receptor 7 agonist
0,381  0,021  Flavin-containing monooxygenase substrate
0,364  0,005  Antieczematic
0,364  0,008  CNS active muscle relaxant
0,362  0,007  Antihelmintic (Nematodes)
0,366  0,013  VCAM1 expression inhibitor
0,385  0,031  Proliferative diseases treatment
0,366  0,013  Phospholipase C inhibitor
0,354  0,002  Aldehyde dehydrogenase substrate
0,384  0,035  NOS2 expression inhibitor
0,387  0,040  Vasodilator, coronary
0,389  0,042  Radioprotector
0,373  0,027  Sodium/bile acid cotransporter inhibitor
0,382  0,042  Lipoxygenase inhibitor
0,386  0,047  CYP2D6 substrate
0,340  0,003  UGT2B10 substrate
0,376  0,043  Antiosteoporotic
0,372  0,039  Chemoprotective
0,338  0,009  Phospholipase A2 inhibitor
0,364  0,034  Tumour necrosis factor alpha release inhibitor
0,340  0,013  Gastrin inhibitor
0,399  0,075  15-Lipoxygenase inhibitor
0,329  0,005  Ferrochelatase inhibitor
0,333  0,011  CYP2B6 inhibitor
0,328  0,009  Antihyperlipoproteinemic
0,360  0,041  Cytotoxic
0,331  0,016  Hair growth stimulant
0,324  0,008  UGT2B9 substrate
0,320  0,005  ATPase inhibitor
0,328  0,013  Antiparkinsonian, tremor relieving
0,329  0,017  Pneumotoxic
0,313  0,006  Adenylate kinase inhibitor
0,324  0,018  UGT1A3 substrate
0,311  0,008  Interleukin 4 antagonist
0,333  0,031  5 Hydroxytryptamine uptake stimulant
0,351  0,052  Spasmolytic
0,299  0,004  Transcription factor NF kappa B stimulant
0,351  0,056  AR expression inhibitor
0,352  0,061  ICAM1 expression inhibitor
0,304  0,013  Glutathione S-transferase substrate
0,295  0,005  Triose-phosphate isomerase inhibitor
0,315  0,029  UGT1A1 substrate
0,375  0,089  Antibacterial
0,302  0,017  Bone formation stimulant
0,305  0,020  Skeletal muscle relaxant
0,307  0,030  RNA-directed DNA polymerase inhibitor
0,295  0,019  Neurotrophic factor enhancer
0,330  0,058  Antineoplastic (pancreatic cancer)
0,297  0,026  Peptidyltransferase inhibitor
0,298  0,032  Antihelmintic
0,272  0,008  Mediator release inhibitor
0,265  0,003  Lysophosphatidic acid 2 receptor antagonist
0,274  0,012  UDP-glucose 4-epimerase inhibitor
0,342  0,082  Stroke treatment
0,261  0,003  GST T1-1 substrate
0,304  0,051  Cardiodepressant
0,289  0,036  Sedative
0,290  0,037  Septic shock treatment
0,376  0,123  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,275  0,023  Insulin sensitizer
0,284  0,032  Non-steroidal antiinflammatory agent
0,255  0,005  Vanilloid 1 agonist
0,256  0,007  Phosphofructokinase-1 inhibitor
0,253  0,006  GABA C receptor antagonist
0,252  0,005  Creatine kinase inhibitor
0,336  0,090  Antiasthmatic
0,259  0,014  Uterine stimulant
0,249  0,005  Arachidonic acid antagonist
0,279  0,036  Muscle relaxant
0,280  0,038  Antihypotensive
0,252  0,009  Antispirochetal
0,276  0,034  P-glycoprotein inhibitor
0,285  0,044  Chemopreventive
0,248  0,008  Antirickettsial
0,265  0,026  Carcinogenic, group 3
0,258  0,018  Insulin secretagoues
0,241  0,002  Anesthetic inhalation
0,254  0,015  Cell wall synthesis inhibitor
0,263  0,024  Muscular dystrophy treatment
0,278  0,040  Wound healing agent
0,243  0,009  Catalase inhibitor
0,258  0,025  UGT2B15 substrate
0,308  0,076  Antifungal
0,240  0,011  UGT2B1 substrate
0,301  0,073  Antineoplastic (ovarian cancer)
0,301  0,073  Metabolic disease treatment
0,245  0,017  SULT1A3 substrate
0,288  0,065  Huntington's disease treatment
0,226  0,004  Acyl-CoA dehydrogenase inhibitor
0,244  0,025  Antidote
0,219  0,004  Antidote, mercury
0,250  0,036  Antiviral (West Nile virus)
0,229  0,015  Excitatory amino acid transporter EAAC1 inhibitor
0,230  0,017  GABA C receptor rho-2 antagonist
0,226  0,015  Microtubule formation inhibitor
0,216  0,008  Adenylate cyclase stimulant
0,235  0,027  Acute respiratory distress syndrome (ARDS) treatment
0,209  0,004  UGT2B11 substrate
0,212  0,007  Carbamoyl phosphate synthetase inhibitor
0,208  0,003  Ca2+-transporting ATPase inhibitor
0,265  0,061  Cytostatic
0,234  0,032  Interferon gamma antagonist
0,207  0,008  Sphingomyelinase inhibitor
0,295  0,096  Calcium channel activator
0,206  0,009  Sphingosine 1-phosphate receptor 5 antagonist
0,204  0,008  Prolactin inhibitor
0,213  0,018  Toll-Like receptor 2 antagonist
0,208  0,013  Coagulant
0,216  0,021  5-Lipoxygenase inhibitor
0,220  0,025  Hexokinase inhibitor
0,226  0,033  Anesthetic
0,206  0,013  Antineoplastic, alkylator
0,199  0,007  Ornithine carbamoyltransferase inhibitor
0,200  0,008  GABA C receptor rho-1 antagonist
0,199  0,007  Antiviral (Papilloma)
0,212  0,022  Cystathionine beta-synthase inhibitor
0,238  0,047  Hepatoprotectant
0,246  0,057  Antiviral (HIV)
0,200  0,013  Mucolytic
0,222  0,037  Amylase inhibitor
0,189  0,005  Thioredoxin reductase inhibitor
0,218  0,035  Melanin inhibitor
0,198  0,016  MAP3K9 inhibitor
0,277  0,096  Antineoplastic (brain cancer)
0,200  0,020  Antiviral (Poxvirus)
0,191  0,011  Carcinogenic, group 2A
0,184  0,006  Paget's disease treatment
0,185  0,007  Cannabinoid CB1 receptor agonist
0,187  0,009  Keratolytic
0,211  0,034  Corneal wound healing stimulator
0,179  0,004  Endocannabinoid uptake inhibitor
0,229  0,056  DNA methyltransferase I inhibitor
0,189  0,015  Photosensitizer
0,194  0,022  Expectorant
0,209  0,036  Neuropathy treatment
0,213  0,042  Antiviral (Herpes)
0,185  0,014  Porphobilinogen synthase inhibitor
0,194  0,023  Retinoprotector
0,183  0,012  NADH dehydrogenase inhibitor
0,190  0,019  Choleretic
0,183  0,013  Sphingosine 1-phosphate receptor 2 antagonist
0,193  0,023  Carcinogenic, group 2B
0,187  0,018  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,171  0,004  Antiviral (Parainfluenza)
0,183  0,017  Contraceptive female
0,222  0,057  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,174  0,009  Glutamate decarboxylase inhibitor
0,190  0,029  Cholesterol synthesis inhibitor
0,189  0,029  Gout treatment
0,185  0,025  Aminopeptidase B inhibitor
0,194  0,035  Aldose reductase substrate
0,209  0,049  5 Hydroxytryptamine 3E antagonist
0,172  0,015  Actinic keratosis treatment
0,180  0,023  SULT1A1 substrate
0,184  0,027  Antiprotozoal (Trichomonas)
0,173  0,017  Sphingosine 1-phosphate receptor 4 antagonist
0,218  0,063  Nitric-oxide synthase stimulant
0,165  0,010  Peroxisome proliferator-activated receptor gamma agonist
0,166  0,011  Anabolic
0,186  0,031  Alkylator
0,224  0,069  Psychostimulant
0,163  0,009  Interferon agonist
0,189  0,035  Raynaud's phenomenon treatment
0,200  0,047  Urolithiasis treatment
0,281  0,128  Antineoplastic (breast cancer)
0,167  0,013  Glutamate dehydrogenase inhibitor
0,203  0,052  LDLR expression enhancer
0,200  0,049  Antipruritic
0,172  0,021  Antiviral (CMV)
0,154  0,007  ATPase (Vacuolar H+) inhibitor
0,232  0,086  Myocardial infarction treatment
0,185  0,039  Antiprotozoal (Coccidial)
0,167  0,022  Sulfotransferase substrate
0,152  0,007  Antiviral (Dengue virus)
0,192  0,048  Aldehyde oxidase substrate
0,155  0,011  Phenylalanine 4-hydroxylase inhibitor
0,181  0,038  Monophenol monooxygenase inhibitor
0,162  0,021  Antiviral (Influenza B)
0,145  0,004  Prostaglandin agonist
0,145  0,004  Vanilloid 2 antagonist
0,148  0,007  Glycine receptor agonist
0,145  0,004  Estrogen-related receptor beta agonist
0,142  0,003  Glucose-6-phosphate isomerase inhibitor
0,172  0,033  Farnesoid X receptor antagonist
0,210  0,073  DNA methylase inhibitor
0,145  0,008  Hyperparathyroidism treatment
0,171  0,034  Hearing loss treatment
0,189  0,053  Cytidine deaminase inhibitor
0,174  0,038  DNA polymerase I inhibitor
0,145  0,009  Sphingosine 1-phosphate receptor 4 agonist
0,154  0,018  Electron transport complex I inhibitor
0,141  0,005  Prostaglandin F2 alpha antagonist
0,225  0,091  Antipyretic
0,173  0,040  Anesthetic local
0,157  0,024  AMP-activated protein kinase stimulant
0,136  0,004  GABA transporter 2 inhibitor
0,136  0,005  Aconitate hydratase inhibitor
0,145  0,013  Aminopeptidase I inhibitor
0,143  0,012  Argininosuccinate synthase inhibitor
0,142  0,011  Leukotriene antagonist
0,134  0,005  Glucosylceramidase inhibitor
0,141  0,012  Toll-Like receptor 2 agonist
0,238  0,108  Insulysin inhibitor
0,134  0,004  Sphingosine kinase inhibitor
0,155  0,026  Potassium channel (Ca-activated) activator
0,218  0,089  Antiprotozoal (Leishmania)
0,142  0,014  Ornithine decarboxylase inhibitor
0,181  0,054  Interleukin 6 antagonist
0,132  0,004  Sphingosine kinase 2 inhibitor
0,135  0,008  Antiviral (RSV)
0,135  0,008  Antiviral (Herpesvirus 3, Human)
0,148  0,022  Antifungal (Pneumocystis)
0,136  0,009  Antidote, heavy metal
0,179  0,053  Catenin beta inhibitor
0,147  0,021  Alcohol dehydrogenase inhibitor
0,136  0,011  Biliverdin reductase inhibitor
0,138  0,015  Interleukin 5 antagonist
0,148  0,026  HIV-1 integrase (Overall Integration) inhibitor
0,126  0,003  Lysophosphatidic acid 3 receptor antagonist
0,168  0,046  Antianemic
0,137  0,015  Restless leg syndrome treatment
0,144  0,022  Electrolyte absorption antagonist
0,124  0,005  Antidote, organophosphates
0,284  0,165  Antiarthritic
0,144  0,025  DOPA decarboxylase inhibitor
0,180  0,061  Antineoplastic (bone cancer)
0,265  0,147  CYP2C9 inhibitor
0,125  0,007  Interferon inducer
0,128  0,010  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,155  0,037  Antineoplastic antimetabolite
0,123  0,006  Vanilloid 4 agonist
0,138  0,022  MAP kinase kinase 1 inhibitor
0,134  0,019  Lanosterol 14 alpha demethylase inhibitor
0,178  0,063  Toxic, respiratory center
0,157  0,042  Cyclooxygenase 3 inhibitor
0,141  0,026  Arylamine N-Acetyltransferase substrate
0,156  0,042  Antibacterial (Helicobacter pylori)
0,211  0,098  Antineoplastic (liver cancer)
0,260  0,147  Antiobesity
0,146  0,034  TRPA1 agonist
0,188  0,076  VEGF expression inhibitor
0,128  0,017  CDC25A inhibitor
0,154  0,043  Cathepsin H inhibitor
0,144  0,033  Caspase 3 inhibitor
0,124  0,013  Granulocyte macrophage colony stimulating factor agonist
0,155  0,044  Proteasome inhibitor
0,162  0,051  Antifungal enhancer
0,116  0,005  Squalene synthetase inhibitor
0,128  0,019  Glutathione S-transferase inhibitor
0,218  0,113  Transcription factor STAT3 inhibitor
0,228  0,124  12-Lipoxygenase inhibitor
0,137  0,033  Myasthenia Gravis treatment
0,137  0,033  Gastric antisecretory
0,132  0,029  Calcium antagonist
0,221  0,118  Antiepileptic
0,159  0,057  Antiacne
0,169  0,066  Antiviral (Hepatitis C)
0,179  0,077  Antiviral (Hepatitis)
0,110  0,008  Gaucher disease treatment
0,162  0,060  Antinephritic
0,105  0,003  Membrane dipeptidase inhibitor
0,161  0,060  Thiol protease inhibitor
0,111  0,010  Peroxisome proliferator-activated receptor alpha agonist
0,151  0,051  Pregnane X receptor agonist
0,109  0,009  Thromboxane antagonist
0,104  0,004  GABA uptake inhibitor
0,136  0,036  Sphingosine 1-phosphate receptor 2 agonist
0,108  0,008  Glutamate (mGluR6) antagonist
0,132  0,032  Acetylcholine release stimulant
0,103  0,004  Sphingosine kinase 1 inhibitor
0,151  0,054  Skin whitener
0,191  0,095  Antialcoholic
0,251  0,154  Antineoplastic (non-Hodgkin's lymphoma)
0,215  0,118  Transcription factor STAT inhibitor
0,137  0,042  Shock treatment
0,213  0,119  Renal disease treatment
0,141  0,047  Gastritis treatment
0,113  0,019  Potassium channel large-conductance Ca-activated activator
0,099  0,005  Retinoid X alpha receptor agonist
0,115  0,021  Cannabinoid receptor agonist
0,114  0,020  Na+ K+ transporting ATPase inhibitor
0,105  0,012  Acetyl-CoA transferase inhibitor
0,195  0,102  Free radical scavenger
0,128  0,036  Toll-Like receptor 4 antagonist
0,100  0,009  Exportin-1 inhibitor
0,116  0,025  Tocolytic
0,164  0,073  Neurotensin receptor agonist
0,104  0,014  GABA B receptor agonist
0,103  0,012  Glycine transporter 2 inhibitor
0,096  0,006  Squalene epoxidase inhibitor
0,131  0,041  Antihelmintic (Fasciola)
0,112  0,023  Glycine receptor antagonist
0,102  0,013  Phospholipase D inhibitor
0,190  0,101  Cyclic AMP phosphodiesterase inhibitor
0,125  0,037  Antineoplastic antibiotic
0,096  0,008  Thromboxane A2 antagonist
0,145  0,058  Heat shock protein 70 antagonist
0,095  0,007  Alpha-mannosidase inhibitor
0,108  0,022  GABA aminotransferase inhibitor
0,126  0,040  Carbonic anhydrase III inhibitor
0,099  0,013  Antimycoplasmal
0,125  0,039  Antiprotozoal (Toxoplasma)
0,094  0,009  Nicotinic alpha3beta2 receptor antagonist
0,108  0,023  Antiviral (Hepatitis A)
0,096  0,011  Leukotriene B4 antagonist
0,137  0,053  Antiprotozoal (Amoeba)
0,147  0,063  Antifungal (Cryptococcus)
0,136  0,053  Growth stimulant
0,098  0,017  CDC25B inhibitor
0,097  0,016  MAP kinase kinase 7 inhibitor
0,085  0,004  Prostaglandin E2 agonist
0,124  0,044  Carbonic anhydrase XV inhibitor
0,089  0,009  Thromboxane synthase inhibitor
0,084  0,004  GABA transporter 3 inhibitor
0,086  0,006  Fumarate hydratase inhibitor
0,086  0,006  Retinoid X receptor agonist
0,114  0,035  Thioredoxin inhibitor
0,081  0,003  Estrogen-related receptor beta antagonist
0,153  0,075  Diuretic
0,127  0,049  Falcipain 3 inhibitor
0,111  0,034  Phosphodiesterase 6D inhibitor
0,080  0,004  Prostaglandin D2 agonist
0,109  0,033  Bile acid receptor antagonist
0,077  0,002  Prostaglandin F2 alpha agonist
0,135  0,061  MAP kinase kinase inhibitor
0,082  0,009  Adenosine deaminase inhibitor
0,082  0,008  Mannosidase inhibitor
0,076  0,002  Lysophosphatidic acid receptor 1 agonist
0,081  0,008  Leukotriene C antagonist
0,080  0,007  Pregnane X receptor antagonist
0,102  0,030  mTOR complex 2 inhibitor
0,076  0,004  Kainate receptor agonist
0,090  0,019  Uterine relaxant
0,144  0,074  Neuropeptide Y1 antagonist
0,074  0,004  Prostacyclin agonist
0,099  0,029  NAT1 substrate
0,129  0,060  Adenylate cyclase inhibitor
0,101  0,032  Histidine decarboxylase inhibitor
0,267  0,198  Alzheimer's disease treatment
0,070  0,002  Lysophosphatidic acid receptor 3 agonist
0,096  0,029  Leukotriene synthesis inhibitor
0,082  0,016  Sphingosine 1-phosphate receptor 3 antagonist
0,160  0,094  Phobic disorders treatment
0,140  0,074  Mannose-6-phosphate isomerase inhibitor
0,084  0,019  Nitric oxide donor
0,075  0,010  Adenylate cyclase 1 inhibitor
0,116  0,051  Antiinfertility, female
0,186  0,121  Antineoplastic (renal cancer)
0,084  0,020  SULT2A1 substrate
0,089  0,025  Anticholelithogenic
0,103  0,038  Glutamate release inhibitor
0,098  0,033  Nicotinic alpha4beta2 receptor antagonist
0,094  0,030  Narcotic antagonist
0,072  0,008  Kainate receptor 2 antagonist
0,216  0,152  CYP3A4 inhibitor
0,146  0,083  CF transmembrane conductance regulator agonist
0,081  0,018  MDM2 inhibitor
0,194  0,131  Neuropeptide Y2 antagonist
0,086  0,023  Cannabinoid CB2 receptor agonist
0,170  0,107  Anticonvulsant
0,132  0,070  Renal failure treatment
0,086  0,024  Prostaglandin EP2 antagonist
0,097  0,036  Antibiotic
0,132  0,070  Nav1.2 sodium channel blocker
0,066  0,004  Prostaglandin EP2 agonist
0,120  0,059  Transcription factor STAT6 inhibitor
0,140  0,079  Cyclooxygenase inhibitor
0,076  0,016  Postcoital contraceptive
0,082  0,022  Beta 3 adrenoreceptor antagonist
0,088  0,028  Antitreponemal
0,156  0,097  Lipocortins synthesis antagonist
0,083  0,024  Neuraminidase inhibitor
0,078  0,020  Antimetabolite
0,140  0,082  Hemostatic
0,066  0,009  Cytokine production stimulant
0,143  0,086  Protein-tyrosine phosphatase inhibitor
0,066  0,009  Geranyltranstransferase inhibitor
0,102  0,048  Antifungal (Candida)
0,080  0,025  Purinergic P2X1 antagonist
0,065  0,010  Phosphoglycerate kinase inhibitor
0,095  0,040  NAD(P)H dehydrogenase (quinone) inhibitor
0,060  0,005  Uridine phosphorylase inhibitor
0,075  0,021  Cannabinoid CB2 receptor antagonist
0,088  0,035  SULT1A2 substrate
0,079  0,026  Neuraminidase (influenza) inhibitor
0,087  0,034  Sphingosine 1-phosphate receptor antagonist
0,116  0,063  Estrogen antagonist
0,078  0,025  Ribonucleoside-diphosphate reductase inhibitor
0,060  0,007  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,057  0,005  Vanilloid 3 antagonist
0,070  0,018  Sphingosine 1-phosphate receptor 1 antagonist
0,101  0,048  Antiviral (Rhinovirus)
0,076  0,024  Hypercalcemia treatment
0,107  0,055  Chronic obstructive bronchitis treatment
0,079  0,027  Ribonucleotide reductase inhibitor
0,105  0,053  Nitric-oxide synthase inhibitor
0,054  0,003  Estrogen-related receptor gamma antagonist
0,117  0,066  Menstruation disorders treatment
0,081  0,031  Potassium channel (Tandem pore domain) blocker
0,058  0,007  Retinoid X receptor antagonist
0,057  0,007  Sodium-dependent vitamin C transporter 2 inhibitor
0,103  0,053  Tourette's syndrome treatment
0,093  0,044  Carbonic anhydrase VI inhibitor
0,171  0,122  Antiviral (Ebola)
0,056  0,007  Leukotriene C4 antagonist
0,081  0,032  Peroxisome proliferator-activated receptor gamma antagonist
0,093  0,044  Topoisomerase II alpha inhibitor
0,067  0,020  Dihydroorotate oxidase inhibitor
0,083  0,037  Phosphodiesterase VI inhibitor
0,056  0,010  Retinoic acid alpha receptor agonist
0,059  0,014  Thymidine kinase inhibitor
0,056  0,011  Acetyl-CoA transferase 1 inhibitor
0,058  0,013  Guanylate cyclase inhibitor
0,081  0,036  S-adenosyl-L-methionine decarboxylase inhibitor
0,059  0,014  Neuraminidase (Influenza A) inhibitor
0,057  0,012  Nicotinic acid receptor agonist
0,207  0,162  Antihypertensive
0,075  0,031  Protease 3C (Human rhinovirus) inhibitor
0,050  0,006  Retinoid X alpha receptor antagonist
0,123  0,080  Toll-Like receptor antagonist
0,053  0,010  Glutamate (mGluR8) agonist
0,092  0,049  Antileprosy
0,080  0,037  Selectin antagonist
0,075  0,032  NMDA receptor agonist
0,054  0,011  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,049  0,007  Sodium/glucose cotransporter 2 inhibitor
0,139  0,097  Movement disorders treatment
0,067  0,025  Lipocortins synthesis agonist
0,056  0,014  Dopamine D5 agonist
0,141  0,100  Cystic fibrosis treatment
0,073  0,032  Cannabinoid CB1 receptor antagonist
0,068  0,028  Beta 1 adrenoreceptor antagonist
0,058  0,017  Kainate receptor antagonist
0,068  0,027  Fatty acid synthase inhibitor
0,048  0,008  Ceramide glucosyltransferase inhibitor
0,056  0,015  Sphingosine 1-phosphate receptor 1 agonist
0,065  0,025  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,106  0,066  CDC-like kinase 3 inhibitor
0,053  0,013  Arginase inhibitor
0,092  0,053  Androgen antagonist
0,049  0,009  Purinergic P2T antagonist
0,045  0,006  Sodium/glucose cotransporter inhibitor
0,059  0,021  Oleamide hydrolase inhibitor
0,052  0,015  Sphingosine 1-phosphate receptor 3 agonist
0,047  0,011  Leukotriene D4 antagonist
0,071  0,035  NMDA receptor glycine site agonist
0,056  0,020  Oxytocin agonist
0,105  0,069  Protein kinase C gamma inhibitor
0,068  0,033  Calcium channel P-type blocker
0,040  0,006  Prostaglandin EP4 agonist
0,109  0,076  Mental retardation treatment
0,047  0,014  Cholesterol absorption inhibitor
0,039  0,006  Prostaglandin H2 antagonist
0,080  0,048  Estrogen receptor alpha antagonist
0,036  0,004  GABA transporter inhibitor
0,104  0,072  GABA receptor agonist
0,075  0,044  Cannabinoid receptor antagonist
0,042  0,010  Leukotriene B4 receptor 1 antagonist
0,074  0,043  Secretase beta inhibitor
0,045  0,014  Peroxisome proliferator-activated receptor delta agonist
0,042  0,011  Hypoxanthine phosphoribosyltransferase inhibitor
0,035  0,004  Isoleucine-tRNA ligase inhibitor
0,105  0,074  Protein-tyrosine phosphatase 1B inhibitor
0,040  0,010  Calcium-independent phospholipase A2 inhibitor
0,035  0,004  Monocarboxylic acid transporter inhibitor
0,035  0,004  Monocarboxylic acid transporter 1 inhibitor
0,053  0,022  Sphingosine 1-phosphate receptor agonist
0,033  0,003  Thromboxane A2 agonist
0,080  0,050  Carbonic anhydrase XIII inhibitor
0,069  0,040  Beta adrenoreceptor antagonist
0,115  0,086  Cyclooxygenase 2 inhibitor
0,039  0,010  Glutamate (mGluR3) agonist
0,033  0,004  Retinoid X beta receptor antagonist
0,048  0,020  Angiotensin AT1 receptor antagonist
0,051  0,023  Fructose-1,6-bisphosphatase inhibitor
0,034  0,006  Vanilloid 2 agonist
0,032  0,005  G-protein-coupled receptor 120 agonist
0,032  0,004  Neuraminidase (Influenza B) inhibitor
0,069  0,042  Andropause treatment
0,052  0,025  Purinergic P2Y antagonist
0,035  0,008  Nicotinic acid receptor 2 antagonist
0,057  0,031  Immunoglobulin Fc receptor antagonist
0,084  0,059  Myeloperoxidase inhibitor
0,039  0,014  Nucleoside transporters inhibitor
0,029  0,004  Vitamin D receptor agonist
0,029  0,005  Toll-Like receptor 8 agonist
0,060  0,035  Carbonic anhydrase VB inhibitor
0,030  0,006  Lysophosphatidic acid 1 receptor antagonist
0,100  0,076  Antihypermotility
0,027  0,003  Thromboxane agonist
0,028  0,005  Carbonic anhydrase VIII inhibitor
0,028  0,005  Carbonic anhydrase X inhibitor
0,032  0,009  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,038  0,015  Melatonin receptor 1A agonist
0,052  0,029  HCV NS3/NS4A protease inhibitor
0,034  0,011  Purinergic P2Y15 antagonist
0,057  0,034  Epithelial sodium channel blocker
0,240  0,217  Calcium channel L-type activator
0,027  0,005  Estrogen-related receptor gamma agonist
0,030  0,009  Glutamate (mGluR1a) agonist
0,057  0,036  Acetylcholine muscarinic agonist
0,038  0,017  HMG CoA reductase inhibitor
0,068  0,047  Glutamate (mGluR7) antagonist
0,027  0,007  Retinoic acid beta receptor agonist
0,030  0,010  Glutamate (mGluR1) agonist
0,031  0,012  Hedgehog signaling activator
0,060  0,041  Androgen agonist
0,042  0,024  NMDA receptor subunit 3A antagonist
0,027  0,009  Vitamin D receptor antagonist
0,037  0,019  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,022  0,004  GABA transporter 1 inhibitor
0,030  0,012  Thymidine phosphorylase inhibitor
0,069  0,051  Protein kinase C beta inhibitor
0,030  0,012  Retinoid X gamma receptor antagonist
0,022  0,005  O6-alkylguanine-DNA alkyltransferase inhibitor
0,162  0,144  Acute neurologic disorders treatment
0,025  0,007  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,040  0,022  Progesterone antagonist
0,048  0,031  Aldosterone antagonist
0,040  0,023  Factor XIIIa inhibitor
0,061  0,044  Beta 2 adrenoreceptor agonist
0,027  0,010  Leukotriene B4 receptor 2 antagonist
0,058  0,041  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,098  0,081  Chelator
0,066  0,049  Antihemophilic
0,026  0,010  Retinoic acid gamma receptor agonist
0,031  0,015  Lysine carboxypeptidase inhibitor
0,104  0,088  Antiviral (Hepatitis B)
0,028  0,012  Sodium/glucose cotransporter 1 inhibitor
0,021  0,006  Telomerase stimulant
0,117  0,102  Psychosexual dysfunction treatment
0,025  0,011  ICAM 1 antagonist
0,021  0,007  Methylmalonyl-CoA mutase inhibitor
0,080  0,066  CC chemokine 5 receptor agonist
0,026  0,012  Kainate receptor 1 antagonist
0,041  0,028  Liver X receptor alpha agonist
0,035  0,022  Angiotensin II receptor antagonist
0,039  0,026  G protein-coupled receptor agonist
0,103  0,090  Interleukin 8 antagonist
0,113  0,100  Antihemorrhagic
0,035  0,022  Free fatty acid receptor 1 antagonist
0,055  0,042  Xanthine dehydrogenase inhibitor
0,034  0,022  Prostacyclin antagonist
0,037  0,025  Glutamate (mGluR3) antagonist
0,046  0,034  Potassium channel Kv1.3 blocker
0,108  0,097  Antismoking
0,016  0,004  Immunosuppressant Cyclosporine-like
0,141  0,130  MAP kinase kinase 2 inhibitor
0,049  0,038  Factor III inhibitor
0,025  0,014  Peroxisome proliferator-activated receptor alpha antagonist
0,021  0,010  Antibiotic Anthracycline-like
0,072  0,062  Macrophage migration inhibitory factor inhibitor
0,024  0,014  GRP78 expression inhibitor
0,029  0,019  Liver X receptor beta antagonist
0,111  0,101  Antihelmintic (Trematoda)
0,124  0,115  Growth hormone agonist
0,037  0,027  Diamine oxidase inhibitor
0,024  0,015  Retinoic acid receptor agonist
0,044  0,035  Microtubule stabilization
0,033  0,024  Liver X receptor beta agonist
0,079  0,071  D-Ala-D-Ala ligase inhibitor
0,171  0,163  Antineurogenic pain
0,126  0,118  MAP kinase 3 inhibitor
0,029  0,021  Liver X receptor alpha antagonist
0,090  0,083  Estrogen receptor beta antagonist
0,040  0,033  Acetylcholine M1 receptor agonist
0,023  0,016  Fructose-1,6-bisphosphatase 1 inhibitor
0,047  0,041  Beta 2 adrenoreceptor antagonist
0,018  0,011  Vesicular glutamate transport inhibitor
0,032  0,025  Calcitonin receptor agonist
0,062  0,056  Potassium channel (ATP-sensitive) blocker
0,076  0,070  Antiprotozoal activity enhancer
0,038  0,033  Glutamate (mGluR1a) antagonist
0,009  0,005  Mannitol 2-dehydrogenase inhibitor
0,041  0,037  Dihydroorotase inhibitor
0,040  0,037  Glutamate (mGluR4) antagonist
0,085  0,081  Xanthine oxidase inhibitor
0,046  0,042  Equilibrative nucleoside transport protein inhibitor
0,012  0,009  Glutamate (mGluR6) agonist
0,036  0,033  Histone deacetylase 9 inhibitor
0,029  0,026  Elastase 2B inhibitor
0,029  0,026  Elastase 3A inhibitor
0,029  0,026  Elastase 3B inhibitor
0,015  0,012  Purinergic P2Y1 agonist
0,021  0,018  Purinergic P2Y12 antagonist
0,026  0,023  LFA antagonist
0,013  0,010  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,053  0,050  Carbonic anhydrase stimulant
0,024  0,022  Acid ceramidase inhibitor
0,027  0,025  Acetylcholine M4 receptor agonist
0,011  0,009  Purine nucleoside phosphorylase inhibitor
0,027  0,024  DNA polymerase III inhibitor
0,083  0,081  ABCA1 expression enhancer
0,020  0,018  Excitatory amino acid transporter 3 inhibitor
0,035  0,034  Dihydropteroate synthase inhibitor
0,160  0,158  DNA damaging
0,049  0,048  Heparanase inhibitor
0,032  0,031  Histone deacetylase 7 inhibitor
0,010  0,009  Calcineurin inhibitor
0,045  0,044  Prostaglandin antagonist
0,023  0,022  Prostaglandin EP4 antagonist
0,169  0,168  Amyotrophic lateral sclerosis treatment
0,025  0,025  Nicotinic alpha4beta2 receptor agonist
0,028  0,027  Cyclophilin A inhibitor
0,063  0,063  Calcium channel L-type blocker
0,033  0,033  Farnesoid X receptor agonist

